Furthermore, we recently reported a novel dominant negative mutation in PPARγ LBD, Ser289Cys, associated with colorectal cancer, dyslipidemia, hypertension, and overweight, but no with T2DM. Here, PPARG is linked to type 2 diabetes mellitus.